Actionable insights straight to your inbox

Equities logo

Aurora Cannabis and Radient Technologies Announce Extension Towards Finalizing Agreement

Both parties have agreed to a 17-day extension, through November 6, 2017, on the 140-day term under which Aurora was granted certain exclusive rights to negotiate with Radient in respect to the acquisition of certain exclusive rights to use Radient's techn

and EDMONTON, Oct. 23, 2017 /CNW/ – Aurora Cannabis Inc. (“Aurora”)
(TSX: ACB) and Radient Technologies Inc. (“Radient”) (TSXV: RTI)
(collectively “the Corporations”), today announced that further to the
companies’ joint press release of June 5, 2017, both parties have agreed to a 17-day extension, through November 6, 2017,
on the 140-day term under which Aurora was granted certain exclusive
rights to negotiate with Radient in respect to the acquisition of
certain exclusive rights to use Radient’s technology and processes, as
further set out in the original memorandum of understanding, dated December 13, 2016.
Good progress has been made towards finalizing the agreement, and both
parties have agreed that the inclusion in the negotiations of certain
additional items warrants an extension to the original 140-day term.

About Aurora

Aurora’s wholly-owned subsidiary, Aurora
Cannabis Enterprises Inc., is a licensed producer of medical cannabis
pursuant to Health Canada’s Access to Cannabis for Medical Purposes
Regulations (“ACMPR”). Aurora operates a 55,200 square foot,
state-of-the-art production facility in Mountain View County, Alberta,
known as “Aurora Mountain”, is currently constructing a second 800,000
square foot production facility, known as “Aurora Sky”, at the Edmonton International Airport, and has acquired, and is undertaking completion of a third 40,000 square foot production facility in Pointe-Claire, Quebec, on Montreal’s West Island.

In addition, Aurora holds approximately 9.6%
of the issued shares (12.9% on a fully-diluted basis) in leading
extraction technology company Radient Technologies Inc., based in Edmonton, and is in the process of completing an investment in Edmonton-based
Hempco Food and Fiber for an ownership stake of up to 50.1%.
Furthermore, Aurora is the cornerstone investor with a 19.9% stake in
Cann Group Limited, the first Australian company licensed to conduct
research on and cultivate medical cannabis. Aurora also owns Pedanios, a
leading wholesale importer, exporter, and distributor of medical
cannabis in the European Union, based in Germany.
Aurora offers further differentiation through its acquisition of BC
Northern Lights Ltd. and Urban Cultivator Inc., industry leaders,
respectively, in the production and sale of proprietary systems for the
safe, efficient and high-yield indoor cultivation of cannabis, and in
state-of-the-art indoor gardening appliances for the cultivation of
organic microgreens, vegetables and herbs in home and professional
kitchens. Aurora’s common shares trade on the TSX under the symbol
“ACB”. Visit for more information.

About Radient

Radient extracts natural compounds from a range of biological materials using its proprietary MAPTM
natural product extraction technology platform which provides superior
customer outcomes in terms of ingredient purity, yield, and cost. From
its initial 20,000 square foot manufacturing plant in Edmonton, Alberta,
Radient serves market leaders in industries that include
pharmaceutical, food, beverage, natural health, personal care and
biofuel markets. Visit for more information.

On behalf of the Board of Directors,
Denis Taschuk, CEO
Terry Booth, CEO

Information set forth in this news release
contains forward-looking information and statements that are based on
assumptions as of the date of this news release. These statements
reflect management’s current estimates, beliefs, intentions and
expectations. They are not guarantees of future performance. The terms
and phrases “goal”, “commitment”, “guidance”, “expects”, “would”,
“will”, “continuing”, “drive”, “believes”, “indicate”, “look forward”,
“grow”, “outlook”, “forecasts”, “intend”, and similar terms and phrases
are intended to identify these forward-looking statements. The
Corporations caution that all forward looking information and statements
are inherently uncertain and that actual performance may be affected by
a number of material factors, many of which are beyond the
Corporations’ control. Such factors include, among other things: risks
and uncertainties relating to the Corporations’ ability to finalize the
terms of the proposed agreement. Accordingly, actual and future events,
conditions and results may differ materially from the estimates,
beliefs, intentions and expectations expressed or implied in the forward
looking information. Except as required under applicable securities
legislation, the Corporations undertake no obligation to publicly update
or revise forward-looking information.

Neither TSX nor TSX Venture Exchange nor
their Regulation Services Providers (as that term is defined in the
policies of the respective Exchanges) accepts responsibility for the
adequacy or accuracy of this release.

SOURCE Aurora Cannabis Inc.

For further information: For Aurora: Cam Battley, Executive Vice
President, +1.905.864.5525, [email protected]; Marc Lakmaaker, NATIONAL
Equicom, +1.416.848.1397, [email protected]; For Radient: Denis
Taschuk, Chief Executive Officer, +1.780.465.1318,
[email protected]; Mike Cabigon, Chief Operating Officer,
+1.780.465.1318, [email protected]

Organization Profile

Aurora Cannabis Inc.

wholly-owned subsidiary, Aurora Cannabis Enterprises Inc., is a licensed
producer of medical marijuana pursuant to the Marihuana for Medical
Purposes Regulations and operates a 55,200 square foot, expandable,
state-of-the-art production facility in Mountain View County, Alberta,
Canada. Aurora trades on the Canadian Securities Exchange under the
symbol “ACB”.

In the interest of full disclosure, we call the reader’s attention
to the fact that, Inc. is compensated by the companies
profiled in the Spotlight Companies section. The purpose of these
profiles is to provide awareness of these companies to investors in the
micro, small-cap and growth equity community and should not in any way
be considered as a recommendation to buy, sell or hold these securities. is not a registered broker dealer, investment advisor,
financial analyst, investment banker or other investment professional.
We are a publisher of original and third party news and information. All
profiles are based on information that is available to the public. The
information contained herein should not be considered to be complete and
is not guaranteed by to be free from misstatement or
errors. The views expressed are our own and not intended to be the basis
for any investment decision. Readers are reminded to do their own due
diligence when researching any companies mentioned on this website.
Always bear in mind that investing in early-stage companies is risky and
you are encouraged to only invest an amount that you can afford to lose
completely without any change in your lifestyle. Equities has been
compensated with cash, common shares and/or warrants for market
awareness services provided.

A weekly five-point roundup of critical events in the energy transition and the implications of climate change for business and finance.